Fundamental Analysis of Shockwave Medical Inc - Growth / Value Index
SWAV - Valuation Highlights
Valuation Analysis
Tremendous increasing in Book Value last 3 year
Tsr Value Index - Poor Score of 26.56
Price to Earning Ratio is 77.26 and EV to EBITDA is 76.43 suggesting that it is very expensive
Price to Book Ratio of 19.68 suggesting that it is very expensive
Valuation Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Price to Earning | 78.34 | 86.84 | 69.34 % | |
Price to Book | 19.96 | 19.13 | -11.71 % | 17.13 |
Price to Sales | 16.26 | 17.51 | -22.56 % | |
Enterprise Value to EBITDA Multiple | 77.46 | 74.83 | -16.10 % |
SWAV - Profitability Highlights
Profitability Analysis
Excellent QoQ /QoQ FY EPS growth
Company Earning excess return
During the past twelve months, the company has given a strong Return On Equity of 25.47%
All key Trailing Twelve Months Margin growing by 15 %
Company's Net Profit is increasing for last 5 Quarters
EBITDA is continuously increasing for last 3 Years
Steady Growth in EPS for last four quarters
Good Return On Capital Employed of 10.52
Good Net Margin of 20.75% is achieved by the company
Very Low Dividend Yield of 0 %
Profitability Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Return On Equity | 25.47 | 22.03 | -47.86 % | 7.36 |
Return On Asset | 13.07 | 9.40 | -71.88 % | 3.37 |
Net Profit Margin | 20.75 | 20.17 | -54.27 % | 25.29 |
Operating Profit Margin | 20.68 | 22.73 | -10.32 % | 19.38 |
EBITDA Margin | 21.26 | 24.15 | -3.62 % | 19.38 |
Highlights
Market Cap | 12567.69 M |
Enterprise Value | 12974.77 M |
Price/Book TTM | 19.96 |
Outstanding Share | 37543.50 K |
Float/ Outstanding Share | 98.38% |
Dividend Yield | 0 % |
Share Holding
Guru Numbers
Price/Graham No | 8.16 |
Peter Lynch Ratio | -0.523 |
Piotroski F Score | 6.00 |
Altman Z Score | 10.17 |
Sloan Ratio | -0.0311 |
Peter Lynch Fair Value | 106.82 |
SWAV - Growth Highlights
Growth Analysis
Short term positive trend in total sale and net profit
STRONG JUMP IN NET SALE : YoY growth
Tremendous increasing trend in total sale last 3 year
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field | TTM | YoY Growth | QoQ Growth |
---|---|---|---|
Revenue | 787969 K | 49.11 % | 7.80 % |
Gross Profit | 685440 K | 49.47 % | 7.28 % |
EBITDA | 167501 K | 43.70 % | 11.02 % |
Net Profit | 163499 K | 31.81 % | 24.92 % |
EPS | 4.27 | 40.95 % | NA |
SWAV - Stability Highlights
Stability Analysis
Altman Z Score of 10.06 suggests good Stability
Cash ratio of 9.51
Company financial liquidity has improved
Stability Key Ratios
Ratio | Latest FY | Yoy Change | MRQ |
---|---|---|---|
Debt to Equity Ratio | 1.10 | 2107.63 % | 0.980 |
Cash Ratio | 9.51 | 97.84 % | |
Quick Ratio | 10.73 | 76.94 % | 12.61 |
Shareholders Equity | 42.68 | -46.06 % | |
Debt to EBITDA | 4.17 | 1909.03 % |
Historical Valuation Ratios of Shockwave Medical Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Shockwave Medical Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Shockwave Medical Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Shockwave Medical Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)